top of page

Medication Strategies: Treatment Resistant Depression

Medication Strategies: Treatment Resistant Depression
Medication Strategies: Treatment Resistant Depression

Medication Strategies: Treatment-Resistant Depression

Treatment-resistant depression (TRD) can be challenging to manage, but several medication strategies may be considered when initial treatments have not been successful. It's important to note that these strategies should be discussed with a qualified healthcare professional, as they can carry risks and side effects. Here are some approaches commonly used in managing TRD:

  1. Augmentation Therapy: This involves adding a second medication to the initial antidepressant treatment to enhance its effectiveness. Common augmentation agents include lithium, thyroid hormone (T3), atypical antipsychotics (such as aripiprazole, quetiapine, or olanzapine), or other antidepressants with different mechanisms of action (such as bupropion or mirtazapine).

  2. Switching Medications: If the initial antidepressant is not effective, switching to a different antidepressant from a different class may be considered. For example, switching from a selective serotonin reuptake inhibitor (SSRI) to a serotonin-norepinephrine reuptake inhibitor (SNRI) or vice versa.

  3. Combination Therapy: This involves using two or more antidepressants with different mechanisms of action simultaneously. For example, combining an SSRI with an SNRI or mirtazapine.

  4. Receptor Targeting: Some newer medications target specific receptors in the brain that are thought to be involved in depression. For example, drugs that target the N-methyl-D-aspartate (NMDA) receptor, such as ketamine or esketamine, have shown promise in TRD.

  5. Electroconvulsive Therapy (ECT): ECT may be considered for severe, treatment-resistant cases of depression. It involves administering controlled electric currents to the brain, which can produce changes in brain chemistry that may alleviate symptoms of depression.

  6. Transcranial Magnetic Stimulation (TMS): TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain. It has been approved for the treatment of TRD and is an option for those who have not responded to other treatments.

  7. Experimental or Investigational Treatments: In some cases, participation in clinical trials or the use of experimental treatments may be considered for TRD that has not responded to standard therapies.

It's essential for individuals with TRD to work closely with their healthcare providers to develop a treatment plan that takes into account their unique symptoms, medical history, and preferences. Regular monitoring and adjustments to the treatment plan may be necessary to achieve the best outcomes.


Medication Strategies: Treatment-Resistant Depression

To Book a Session with Lev Le'Lev Wellness & Health Center (click here)

We would love it if you joined our Facebook Community Group: Lev Le'Lev - Wellness & Health Community - לב ללב FB Page

Recent Posts

See All


bottom of page